GENPHARMATrading & Distributors
Genpharmasec Ltd — PE Ratio & Valuation Analysis
₹0.78
-7.69%
Current P/E149.01xPrice to earnings
Industry P/E35.45xSector average
4Y Avg P/E219.5x32.1% below avg
⚠️
320.3% Premium to Industry
GENPHARMA P/E 149.01x vs sector avg 35.45x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹0.01 | ₹1 | 131x |
| 2024 | ₹0.01 | ₹3 | 308x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Genpharmasec Ltd Valuation
Genpharmasec Ltd (GENPHARMA) currently trades at 149.01x earnings. The Trading & Distributors sector average PE is 35.45x. GENPHARMA commands a premium, reflecting high growth expectations. Historically, GENPHARMA has traded at an average PE of 219.5x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
1.90%
Dividend Yield
0.00%
More on Genpharmasec Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.